Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Morifumi, Yanagisawa"'
Autor:
Daisuke Ito, Satoshi Shimizu, Akifumi Haisa, Shinnosuke Yanagisawa, Kazuyuki Inoue, Daigo Saito, Takashi Sumita, Morifumi Yanagisawa, Yoshihito Uchida, Kouichi Inukai, Akira Shimada
Publikováno v:
Journal of Diabetes Investigation, Vol 15, Iss 9, Pp 1220-1230 (2024)
ABSTRACT Aims/Introduction We conducted a 5 year post‐trial monitoring study of our previous randomized 24 week, open‐label, active‐controlled trial that showed beneficial effects of ipragliflozin on metabolic dysfunction‐associated steatotic
Externí odkaz:
https://doaj.org/article/c9c943d09a60435ca4995cce217880f0
Autor:
Satoshi Shimizu, Mitsuhiko Noda, Kouichi Inukai, Yoshihiro Morimoto, Yuji Akiyama, Akira Shimada, Morifumi Yanagisawa, Daisuke Ito, Daigo Saito, Kazuyuki Inoue
Publikováno v:
Diabetes Care. 40:1364-1372
OBJECTIVE To compare the efficacy of ipragliflozin versus pioglitazone in patients with type 2 diabetes complicated by nonalcoholic fatty liver disease (NAFLD). RESEARCH DESIGN AND METHODS In this open-label, randomized, active-controlled trial, we r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76dea71ac112ff5052bdd194327d0708
https://doi.org/10.2337/dc17-0518
https://doi.org/10.2337/dc17-0518
Autor:
Mitsuhiko Noda, Kazuyuki Inoue, Emi Ikuma-Suwa, Morifumi Yanagisawa, Kouichi Inukai, Daisuke Ito, Akira Shimada, Kimie Kaneko
Publikováno v:
Journal of Clinical Medicine Research
Background: Sodium-glucose cotransporter 2 (SGLT2) inhibitors are novel agents used to treat type 2 diabetic patients. We investigated the efficacy of the SGLT2 inhibitor ipragliflozin on diabetic nephropathy in Japanese patients with type 2 diabetes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::888db942b05d6dff7b07d3f963661875
https://doi.org/10.14740/jocmr2875w
https://doi.org/10.14740/jocmr2875w
Autor:
Daisuke Ito, Mitsuhiko Noda, Akira Shimada, Kazuyuki Inoue, Keiko Hamaguchi, Ikuo Inoue, Morifumi Yanagisawa, Kimie Kaneko, Kouichi Inukai, Takashi Sumita
Publikováno v:
Journal of Clinical Medicine Research
Background: In our previous study, we investigated the efficacy of ipragliflozin, a sodium-glucose cotransporter (SGLT) 2 inhibitor on diabetic nephropathy in patients with type 2 diabetes and demonstrated that ipragliflozin significantly improved di
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e3373c67d612cd805b046beb44330e8a
https://pubmed.ncbi.nlm.nih.gov/30116437
https://pubmed.ncbi.nlm.nih.gov/30116437
Autor:
Azuma, Kanatsuka, Yasunori, Sato, Koichi, Kawai, Koichi, Hirao, Masashi, Kobayashi, Atsunori, Kashiwagi, Nobuyuki, Abe, Keiko, Arai, Hiroshi, Fujiya, Yoshihide, Fukumoto, Fumihiko, Dake, Tomohiro, Iizumi, Masaaki, Ito, Koichi, Iwasaki, Akira, Kanamori, Sumio, Kato, Masakazu, Kato, Akira, Kawara, Kenichi, Kimura, Kazumasa, Chikamori, Kotaro, Iemitsu, Shigetake, Kou, Mikihiko, Kudo, Yoshio, Kurihara, Gendai, Lee, Akira, Tsuruoka, Naoki, Manda, Kiyokazu, Matoba, Hiroshi, Hayashi, Masae, Minami, Nobuichi, Kuribayashi, Kazuhiro, Miyazawa, Yasuko, Chiba, Takeshi, Osonoi, Shin, Nakamura, Hideo, Sasaki, Katsutoshi, Komori, Mariko, Oishi, Akira, Okada, Fuminobu, Okuguchi, Morifumi, Yanagisawa, Hidekatsu, Sugimoto, Hiromichi, Sugiyama, Masahiko, Takai, Masato, Takaki, Hiroshi, Takamura, Hiroshi, Takeda, Kokichi, Tanaka, Takashi, Miwa, Osamu, Tomonaga, Madoka, Taguchi, Katsuya, Yamazaki, Takako, Wada, Noriharu, Yagi, Kuniko, Yamaoka, Atsuyoshi, Yuhara
Publikováno v:
Journal of Diabetes Investigation
Aims/Introduction We carried out an observational cohort study to examine the relationship between the efficacy of oral antidiabetic drugs and clinical features in type 2 diabetics. Materials and Methods We analyzed the CoDiC® database of the Japan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab0ce84c174c83c23da020f675e03cda
https://doi.org/10.1111/jdi.12430
https://doi.org/10.1111/jdi.12430
Autor:
Hitoshi Ishida, Takashi Sumita, Kimie Kaneko, Takuya Awata, Shigehiro Katayama, Kazuyuki Inoue, Yuichi Ikegami, Daisuke Ito, Kouichi Inukai, Morifumi Yanagisawa
Publikováno v:
Journal of Clinical Medicine Research
Background: In Japan, dipeptidyl peptidase 4 (DPP4) inhibitors have become standard therapeutic agents for type 2 diabetes, and numbers of patients receiving insulin therapy combined with DPP4 inhibitors, which is a highly effective regimen, are incr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a9fbd393a31dd72d225d4da9910039ef
https://doi.org/10.14740/jocmr2057w
https://doi.org/10.14740/jocmr2057w
Autor:
Morifumi Yanagisawa, Noriharu Yagi, Kazumi Saito, Azuma Kanatsuka, Hirohito Sone, Mariko Oishi, Hidekatsu Sugimoto, Takako Wada, Fuminobu Okuguchi, Hiroki Yokoyama, Keiko Arai, Koichi Kawai, Aki Saito, Nobuichi Kuribayashi, Kazuhiro Miyazawa, Koichi Iwasaki
Publikováno v:
Appetite. 59:252-255
We examined whether the rate of eating was associated with the body mass index and glycemic control status in Japanese patients with type 2 diabetes (50% women, mean±SD age 59.4±7.5 years). Rapid eating was significantly associated with body mass i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2caf98fb216554f2611f265327285d65
https://doi.org/10.1016/j.appet.2012.05.009
https://doi.org/10.1016/j.appet.2012.05.009
Autor:
Yumi Mashimo, Suguru Maekawa, Kazuhiro Sugitani, Kuang-I Fu, Keiji Imamaki, Morifumi Yanagisawa, Yoshihiro Morimoto, Shinji Yagi, Takahiro Fujimori
Publikováno v:
Digestive Diseases and Sciences. 50:381-384
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::245128048ecc38a4112796edd7e36469
https://doi.org/10.1007/s10620-005-1614-0
https://doi.org/10.1007/s10620-005-1614-0
Autor:
Kazumasa Hase, Morifumi Yanagisawa, Makoto Iitaka, Jun Ishii, Shiro Miura, Yoshihito Hara, Nobuhiko Fukasawa, Yoshiki Sakatsume
Publikováno v:
Acta Endocrinologica. 123:123-128
The sera from two patients with Graves' disease gave abnormally high serum free T4 values as compared with the total T4 and other hormone values, suggesting the presence of autoantibodies to labelled T4 analogue used in the Amersham free T4 assay kit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e124a272f8cfd7f7b56f64defaf714dd
https://doi.org/10.1530/acta.0.1230123
https://doi.org/10.1530/acta.0.1230123
Autor:
Daisuke Ito, Satoshi Shimizu, Kazuyuki Inoue, Daigo Saito, Morifumi Yanagisawa, Kouichi Inukai, Yuji Akiyama, Yoshihiro Morimoto, Mitsuhiko Noda, Akira Shimada, Ito, Daisuke, Shimizu, Satoshi, Inoue, Kazuyuki, Saito, Daigo, Yanagisawa, Morifumi, Inukai, Kouichi, Akiyama, Yuji, Morimoto, Yoshihiro, Noda, Mitsuhiko, Shimada, Akira
Publikováno v:
Diabetes Care; Oct2017, Vol. 40 Issue 10, p1364-1372, 9p, 3 Charts, 1 Graph